Internal Medicine · Oakland, CA
NPI
1053567685
Since 2008
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
275 W Macarthur Blvd
Oakland, CA, 94611
Phone (510) 752-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$50K
2,735 services
Medicare patients, 2024
27
Average age 67
Drug cost, 2024
$438K
3,362 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Rosa M Valadao prescribed most often to Medicare patients was Gavilyte-C (Peg3350/Sod Sulf,bicarb,cl/Kcl), with 2,594 prescriptions and refills. In total Rosa M Valadao wrote 3,362 Medicare prescriptions that cost $438K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-22.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 2,594 | 2,598 | 2,476 | $60K |
| Pantoprazole Sodium Generic | 193 | 340 | 54 | $2,389 |
| Mesalamine Generic | 61 | 123 | 17 | $29K |
| Omeprazole Generic | 55 | 137 | 28 | $566 |
| Lactulose Generic | 45 | 48 | Under 11 | $2,849 |
| Budesonide Dr Budesonide | 27 | 41 | Under 11 | $1,848 |
| Azathioprine Generic | 19 | 24 | Under 11 | $232 |
| Ondansetron Hcl Generic | 18 | 18 | Under 11 | $206 |
| Ursodiol Generic | 17 | 48 | Under 11 | $3,363 |
| Zenpep Lipase/Protease/Amylase | 17 | 22 | Under 11 | $33K |
| Xifaxan Rifaximin | 16 | 16 | Under 11 | $53K |
| Famotidine Generic | 16 | 39 | Under 11 | $168 |
| Spironolactone Generic | 15 | 35 | Under 11 | $332 |
| Dicyclomine Hcl Generic | 14 | 16 | Under 11 | $296 |
| Ondansetron Odt Ondansetron | 14 | 14 | Under 11 | $138 |
Brand drugs: - claims; generic drugs: 3,229 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Rosa M Valadao were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.